Select a medication above to begin.
Propulsid
cisapride
Black Box Warnings .
Arrhythmias
serious, sometimes fatal cardiac arrhythmias incl. ventricular tachycardia, ventricular fibrillation, torsades de pointes, and QT prolongation reported; many events in combo w/ 3A4 inhibitor drugs that incr. cisapride level; contraindicated w/ 3A4 inhibitors, if hx prolonged QT intervals/known family hx congenital long QT syndrome, renal failure, hx ventricular arrhythmias, ischemic heart dz, CHF, clinically significant bradycardia, uncorrected electrolyte disorders incl. hypokalemia/hypomagnesemia, and resp. failure; contraindicated in combo w/ drugs which prolong QT interval/incr. arrhythmia risk incl. but not limited to class IA/III antiarrhythmics, TCAs, maprotiline, certain phenothiazines, sertindole, astemizole, bepridil, sparfloxacin, and terodiline; do not exceed recommended dose
Adult Dosing .
Dosage forms: TAB: 10 mg, 20 mg; SUSP: 1 mg per mL
Withdrawn from US Market
- [March 2000]
- Info: due to incr. cardiac arrhythmia risk; only avail. under treatment IND protocol; 1-877-795-4247 for more info
Peds Dosing .
- Dosage forms: TAB: 10 mg, 20 mg; SUSP: 1 mg per mL
Withdrawn from US Market
- [March 2000]
- Info: due to cardiac arrhythmia risk; only avail. under treatment IND protocol; 1-877-795-4247 for more info